THROMBOLYTIC THERAPY

被引：93
作者：
COLLEN, D
STUMP, DC
GOLD, HK
机构：
[1] UNIV VERMONT,SCH MED,DEPT BIOCHEM,BURLINGTON,VT 05405
[2] UNIV VERMONT,SCH MED,DEPT MED,BURLINGTON,VT 05405
[3] MASSACHUSETTS GEN HOSP,DIV CARDIOL,BOSTON,MA 02114
[4] HARVARD UNIV,SCH MED,BOSTON,MA 02115
来源：
ANNUAL REVIEW OF MEDICINE | 1988年 / 39卷
关键词：
D O I：
10.1146/annurev.me.39.020188.002201
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：405 / 423
页数：19
相关论文
共 87 条
[1]  
ANDERSON JL, 1986, CIRCULATION, V74, P6
[2]  
[Anonymous], 1986, Lancet, V1, P397
[3]  
[Anonymous], 1974, JAMA-J AM MED ASSOC, V229, P1606
[4]  
BACHMANN F, 1987, THROMB DIATH HAEMO, P227
[5]   ANTIBODY-DIRECTED UROKINASE - A SPECIFIC FIBRINOLYTIC AGENT [J].
BODE, C ;
MATSUEDA, GR ;
HUI, KY ;
HABER, E .
SCIENCE, 1985, 229 (4715) :765-767
[6]  
BODE C, 1987, J AM COLL CARDIOL, V9, pA81
[7]  
BONNIER JJR, 1987, DRUGS S3, V33, P30
[8]   THROMBOLYTIC TREATMENT WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A PATIENT WITH MASSIVE PULMONARY-EMBOLISM [J].
BOUNAMEAUX, H ;
VERMYLEN, J ;
COLLEN, D .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :64-65
[9]   ANNOUNCEMENT OF PROTOCOL CHANGE IN THROMBOLYSIS IN MYOCARDIAL-INFARCTION TRIAL [J].
BRAUNWALD, E ;
KNATTERUD, GL ;
PASSAMANI, ER ;
ROBERTSON, TL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) :467-467
[10]  
BROCHIER ML, 1987, DRUGS S3, V33, P28
123456789